MC
TMO icon

Moors & Cabot’s Thermo Fisher Scientific TMO Stock Holding History

Moors & Cabot’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Sell
3,139
-47
-1% -$25.5K 0.07% 264
2025
Q4 		$1.85M Buy
3,186
+180
+6% +$102K 0.08% 222
2025
Q3 		$1.46M Sell
3,006
-65
-2% -$30.3K 0.06% 271
2025
Q2 		$1.25M Sell
3,071
-293
-9% -$123K 0.06% 287
2025
Q1 		$1.67M Sell
3,364
-503
-13% -$272K 0.08% 213
2024
Q4 		$2.01M Sell
3,867
-75
-2% -$41.2K 0.1% 180
2024
Q3 		$2.44M Buy
3,942
+15
+0.4% +$8.88K 0.12% 160
2024
Q2 		$2.17M Buy
3,927
+67
+2% +$38.4K 0.12% 162
2024
Q1 		$2.24M Sell
3,860
-900
-19% -$505K 0.12% 162
2023
Q4 		$2.53M Sell
4,760
-574
-11% -$278K 0.16% 136
2023
Q3 		$2.7M Buy
5,334
+1,152
+28% +$614K 0.18% 120
2023
Q2 		$2.18M Buy
4,182
+604
+17% +$326K 0.14% 146
2023
Q1 		$2.06M Sell
3,578
-593
-14% -$334K 0.14% 158
2022
Q4 		$2.3M Sell
4,171
-1,226
-23% -$650K 0.16% 143
2022
Q3 		$2.74M Sell
5,397
-291
-5% -$163K 0.21% 108
2022
Q2 		$3.09M Sell
5,688
-103
-2% -$56.7K 0.22% 101
2022
Q1 		$3.42M Sell
5,791
-181
-3% -$104K 0.21% 105
2021
Q4 		$3.98M Buy
5,972
+329
+6% +$205K 0.25% 90
2021
Q3 		$3.23M Sell
5,643
-320
-5% -$176K 0.2% 108
2021
Q2 		$3.01M Sell
5,963
-248
-4% -$117K 0.21% 104
2021
Q1 		$2.83M Buy
6,211
+430
+7% +$205K 0.22% 102
2020
Q4 		$2.69M Sell
5,781
-53
-0.9% -$24.9K 0.23% 100
2020
Q3 		$2.58M Sell
5,834
-398
-6% -$164K 0.24% 96
2020
Q2 		$2.26M Sell
6,232
-322
-5% -$108K 0.24% 94
2020
Q1 		$1.86M Sell
6,554
-971
-13% -$306K 0.27% 90
2019
Q4 		$2.44M Sell
7,525
-361
-5% -$109K 0.24% 105
2019
Q3 		$2.3M Buy
7,886
+5,503
+231% +$1.58M 0.25% 101
2019
Q2 		$699K Sell
2,383
-9
-0.4% -$2.48K 0.09% 236
2019
Q1 		$654K Buy
2,392
+3
+0.1% +$747 0.09% 235
2018
Q4 		$532K Sell
2,389
-1,504
-39% -$353K 0.08% 248
2018
Q3 		$949K Buy
3,893
+499
+15% +$115K 0.12% 197
2018
Q2 		$703K Sell
3,394
-15
-0.4% -$3.18K 0.09% 241
2018
Q1 		$704K Sell
3,409
-916
-21% -$192K 0.09% 252
2017
Q4 		$818K Buy
4,325
+681
+19% +$130K 0.11% 219
2017
Q3 		$686K Buy
3,644
+975
+37% +$177K 0.1% 242
2017
Q2 		$465K Sell
2,669
-199
-7% -$33.4K 0.08% 302
2017
Q1 		$439K Buy
2,868
+428
+18% +$65.4K 0.07% 302
2016
Q4 		$345K Buy
2,440
+282
+13% +$41.6K 0.06% 350
2016
Q3 		$344K Buy
2,158
+164
+8% +$25.3K 0.06% 342
2016
Q2 		$294K Buy
1,994
+7
+0.4% +$1.03K 0.05% 374
2016
Q1 		$281K Sell
1,987
-98
-5% -$13.1K 0.05% 367
2015
Q4 		$295K Buy
2,085
+23
+1% +$3.07K 0.05% 355
2015
Q3 		$249K Buy
+2,062
New +$269K 0.05% 410

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Moors & Cabot's TMO Position: Q1 2026 in Review

Moors & Cabot reduced its Thermo Fisher Scientific (TMO) stake by 1.5% in Q1 2026, selling an estimated $25.5K and leaving 3,139 shares worth $1.54M. The position accounts for 0.07% of the portfolio, ranked #264.

Moors & Cabot first reported a position in TMO in Q3 2015 and has held it in 43 quarters since. The position peaked at $3.98M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Moors & Cabot held 3,139 shares of Thermo Fisher Scientific worth $1.54M as of Q1 2026.
  • Moors & Cabot sold 47 Thermo Fisher Scientific shares in Q1 2026, an estimated $25.5K.
  • Thermo Fisher Scientific made up 0.07% of Moors & Cabot's portfolio in Q1 2026, its #264 holding.
  • Moors & Cabot first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 43 quarters since.
  • Moors & Cabot's Thermo Fisher Scientific position peaked at $3.98M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.